brain ceramides Search Results


98
Croda International Plc phosphatidylethanol
Fig. 2. S1P stimulates phospholipase D (PLD) activity in ZG cells. ZG cells were labeled with 1 mCi/ml [3H]myristate in DMEM containing 0.2% BSA for 3 h. The cells were then washed three times with this same medium, but in the absence of label, and incubated further in BSA-free DMEM for 2.5 h. Cells were stim- ulated with 5 mM S1P for various times (upper panel) or with increasing concentrations of S1P for 30 min, as indicated (lower panel), in the presence of 1% ethanol. <t>[3H]phosphatidylethanol</t> formation was determined as indicated in Materials and Methods. Results were calculated as a percentage of the radioactivity pres- ent in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to incubations with vehicle. Values are means 6 SEM of four independent experi- ments performed in triplicate, except for the value at 5 mM S1P, which is the mean 6 SEM of 15 experiments.
Phosphatidylethanol, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/10__1194_slash_jlr__m500510___jlr200-50-7-10?v=Croda+International+Plc
Average 98 stars, based on 1 article reviews
phosphatidylethanol - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

95
Croda International Plc brain ceramides
Fig. 2. S1P stimulates phospholipase D (PLD) activity in ZG cells. ZG cells were labeled with 1 mCi/ml [3H]myristate in DMEM containing 0.2% BSA for 3 h. The cells were then washed three times with this same medium, but in the absence of label, and incubated further in BSA-free DMEM for 2.5 h. Cells were stim- ulated with 5 mM S1P for various times (upper panel) or with increasing concentrations of S1P for 30 min, as indicated (lower panel), in the presence of 1% ethanol. <t>[3H]phosphatidylethanol</t> formation was determined as indicated in Materials and Methods. Results were calculated as a percentage of the radioactivity pres- ent in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to incubations with vehicle. Values are means 6 SEM of four independent experi- ments performed in triplicate, except for the value at 5 mM S1P, which is the mean 6 SEM of 15 experiments.
Brain Ceramides, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/pmc02883648-127-1-3?v=Croda+International+Plc
Average 95 stars, based on 1 article reviews
brain ceramides - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

90
Matreya LLC ceramide from bovine brain
Fig. 2. S1P stimulates phospholipase D (PLD) activity in ZG cells. ZG cells were labeled with 1 mCi/ml [3H]myristate in DMEM containing 0.2% BSA for 3 h. The cells were then washed three times with this same medium, but in the absence of label, and incubated further in BSA-free DMEM for 2.5 h. Cells were stim- ulated with 5 mM S1P for various times (upper panel) or with increasing concentrations of S1P for 30 min, as indicated (lower panel), in the presence of 1% ethanol. <t>[3H]phosphatidylethanol</t> formation was determined as indicated in Materials and Methods. Results were calculated as a percentage of the radioactivity pres- ent in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to incubations with vehicle. Values are means 6 SEM of four independent experi- ments performed in triplicate, except for the value at 5 mM S1P, which is the mean 6 SEM of 15 experiments.
Ceramide From Bovine Brain, supplied by Matreya LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/pm07592649-26-2-9?v=Matreya+LLC
Average 90 stars, based on 1 article reviews
ceramide from bovine brain - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
FUJIFILM gm2 (galnacβ1,4(neu5acα2,3)galβ1,4glcβ1,1’-ceramide) bovine brain
Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; <t>GM2,</t> ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes
Gm2 (Galnacβ1,4(neu5acα2,3)galβ1,4glcβ1,1’ Ceramide) Bovine Brain, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/pmc11073213-625-0-7?v=FUJIFILM
Average 90 stars, based on 1 article reviews
gm2 (galnacβ1,4(neu5acα2,3)galβ1,4glcβ1,1’-ceramide) bovine brain - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Chemie GmbH bovine brain ceramide type iv
Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; <t>GM2,</t> ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes
Bovine Brain Ceramide Type Iv, supplied by Chemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/10__1111_slash_j__0022___202x__2004__23477__x-128-13-26?v=Chemie+GmbH
Average 90 stars, based on 1 article reviews
bovine brain ceramide type iv - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Matreya LLC ceramide trihexoside from porcine brain
Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; <t>GM2,</t> ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes
Ceramide Trihexoside From Porcine Brain, supplied by Matreya LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/10__1038_slash_s42005___023___01272___3-241-1-27?v=Matreya+LLC
Average 90 stars, based on 1 article reviews
ceramide trihexoside from porcine brain - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Matreya LLC sphingomyelin and ceramide from bovine brain
Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; <t>GM2,</t> ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes
Sphingomyelin And Ceramide From Bovine Brain, supplied by Matreya LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/pm07592649-26-5-9?v=Matreya+LLC
Average 90 stars, based on 1 article reviews
sphingomyelin and ceramide from bovine brain - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

98
Avanti Polar ceramide
Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; <t>GM2,</t> ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes
Ceramide, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/custom%40860052p%409892644?v=Avanti+Polar
Average 98 stars, based on 1 article reviews
ceramide - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

90
Matreya LLC bovine brain ceramides
Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; <t>GM2,</t> ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes
Bovine Brain Ceramides, supplied by Matreya LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/pm11878798-37-0-6?v=Matreya+LLC
Average 90 stars, based on 1 article reviews
bovine brain ceramides - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Matreya LLC brain ceramide
Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; <t>GM2,</t> ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes
Brain Ceramide, supplied by Matreya LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brain+ceramides/pm14622962-111-7-25?v=Matreya+LLC
Average 90 stars, based on 1 article reviews
brain ceramide - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

N/A
Ceramides comprise sphingoid base attached to fatty acyl chain by an amide bond. They vary in length, saturation and hydroxylation of the fatty acid chain and sphingoid base. Ceramides are synthesized by sphingomyelinase in salvage
  Buy from Supplier

Image Search Results


Fig. 2. S1P stimulates phospholipase D (PLD) activity in ZG cells. ZG cells were labeled with 1 mCi/ml [3H]myristate in DMEM containing 0.2% BSA for 3 h. The cells were then washed three times with this same medium, but in the absence of label, and incubated further in BSA-free DMEM for 2.5 h. Cells were stim- ulated with 5 mM S1P for various times (upper panel) or with increasing concentrations of S1P for 30 min, as indicated (lower panel), in the presence of 1% ethanol. [3H]phosphatidylethanol formation was determined as indicated in Materials and Methods. Results were calculated as a percentage of the radioactivity pres- ent in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to incubations with vehicle. Values are means 6 SEM of four independent experi- ments performed in triplicate, except for the value at 5 mM S1P, which is the mean 6 SEM of 15 experiments.

Journal: Journal of Lipid Research

Article Title: Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion

doi: 10.1194/jlr.m500510-jlr200

Figure Lengend Snippet: Fig. 2. S1P stimulates phospholipase D (PLD) activity in ZG cells. ZG cells were labeled with 1 mCi/ml [3H]myristate in DMEM containing 0.2% BSA for 3 h. The cells were then washed three times with this same medium, but in the absence of label, and incubated further in BSA-free DMEM for 2.5 h. Cells were stim- ulated with 5 mM S1P for various times (upper panel) or with increasing concentrations of S1P for 30 min, as indicated (lower panel), in the presence of 1% ethanol. [3H]phosphatidylethanol formation was determined as indicated in Materials and Methods. Results were calculated as a percentage of the radioactivity pres- ent in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to incubations with vehicle. Values are means 6 SEM of four independent experi- ments performed in triplicate, except for the value at 5 mM S1P, which is the mean 6 SEM of 15 experiments.

Article Snippet: Sphingosine, S1P, N-acetylsphingosine (C2-ceramide), N-hexanoylsphingosine (C6-ceramide), and phosphatidylethanol were from Avanti Polar Lipids (Alabaster, AL).

Techniques: Activity Assay, Labeling, Incubation, Radioactivity

Fig. 3. Effect of S1P and angiotensin II on aldosterone secretion and PLD activation in ZG cells. Cells were incubated for 2 h with S1P (5 mM) in the presence (closed bars) or absence (open bars) of angiotensin II (10 nM). Upper panel: Aldosterone secretion was determined as described in Materials and Methods. Results are calculated as described for Fig. 1 and are expressed as means 6 SEM of three independent experiments performed in triplicate. Lower panel: For determination of PLD activity, ethanol (1%) was added 5 min before cell stimulation, and incubations were con- tinued further for 30 min. The enzyme activity was determined by measuring the accumulation of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated as a percentage of the radioactivity present in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stim- ulation relative to control (CTRL) incubations. Values are means 6 SEM of five independent experiments performed in triplicate.

Journal: Journal of Lipid Research

Article Title: Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion

doi: 10.1194/jlr.m500510-jlr200

Figure Lengend Snippet: Fig. 3. Effect of S1P and angiotensin II on aldosterone secretion and PLD activation in ZG cells. Cells were incubated for 2 h with S1P (5 mM) in the presence (closed bars) or absence (open bars) of angiotensin II (10 nM). Upper panel: Aldosterone secretion was determined as described in Materials and Methods. Results are calculated as described for Fig. 1 and are expressed as means 6 SEM of three independent experiments performed in triplicate. Lower panel: For determination of PLD activity, ethanol (1%) was added 5 min before cell stimulation, and incubations were con- tinued further for 30 min. The enzyme activity was determined by measuring the accumulation of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated as a percentage of the radioactivity present in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stim- ulation relative to control (CTRL) incubations. Values are means 6 SEM of five independent experiments performed in triplicate.

Article Snippet: Sphingosine, S1P, N-acetylsphingosine (C2-ceramide), N-hexanoylsphingosine (C6-ceramide), and phosphatidylethanol were from Avanti Polar Lipids (Alabaster, AL).

Techniques: Activation Assay, Incubation, Activity Assay, Cell Stimulation, Radioactivity, Control

Fig. 5. Effect of pertussis toxin (PTX) on aldosterone secretion and PLD activation by S1P in ZG cells. Upper panel: Cells were preincubated in the absence (open bars) or presence (closed bars) of 1 mg/ml PTX for 16 h. S1P (5 mM) or vehicle [control (CTRL)] was then added, as indicated, and the incubations were continued further for 2 h. Aldosterone secretion was determined as described in Materials and Methods. Results are calculated and expressed as described for Fig. 1 and are means 6 SEM of three independent experiments performed in triplicate. Lower panel: Cells were preincubated in the absence (open bars) or presence (closed bars) of 1 mg/ml PTX for 16 h. S1P (5 mM) or vehicle [control (CTRL)] was then added, as indicated. Ethanol (1%) was added 5 min before stimulation with S1P, and incubations continued further for 30 min. PLD activity was determined by measuring the accumula- tion of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated as a percentage of the radioac- tivity present in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to control incubations. Values are means 6 SEM of three independent experiments performed in triplicate. ** P , 0.01; * P , 0.05.

Journal: Journal of Lipid Research

Article Title: Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion

doi: 10.1194/jlr.m500510-jlr200

Figure Lengend Snippet: Fig. 5. Effect of pertussis toxin (PTX) on aldosterone secretion and PLD activation by S1P in ZG cells. Upper panel: Cells were preincubated in the absence (open bars) or presence (closed bars) of 1 mg/ml PTX for 16 h. S1P (5 mM) or vehicle [control (CTRL)] was then added, as indicated, and the incubations were continued further for 2 h. Aldosterone secretion was determined as described in Materials and Methods. Results are calculated and expressed as described for Fig. 1 and are means 6 SEM of three independent experiments performed in triplicate. Lower panel: Cells were preincubated in the absence (open bars) or presence (closed bars) of 1 mg/ml PTX for 16 h. S1P (5 mM) or vehicle [control (CTRL)] was then added, as indicated. Ethanol (1%) was added 5 min before stimulation with S1P, and incubations continued further for 30 min. PLD activity was determined by measuring the accumula- tion of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated as a percentage of the radioac- tivity present in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to control incubations. Values are means 6 SEM of three independent experiments performed in triplicate. ** P , 0.01; * P , 0.05.

Article Snippet: Sphingosine, S1P, N-acetylsphingosine (C2-ceramide), N-hexanoylsphingosine (C6-ceramide), and phosphatidylethanol were from Avanti Polar Lipids (Alabaster, AL).

Techniques: Activation Assay, Control, Activity Assay

Fig. 8. Involvement of extracellular Ca21 in S1P-induced aldoste- rone secretion and PLD activation. Upper panel: Cells were treated as described for Fig. 1 and preincubated for 30 min with 5 mM EGTA (closed bars), 5 mM BAPTA-AM (gray bars), 5 mM EGTA 1 5 mM BAPTA-AM (hatched bars), or vehicle (open bars). They were then stimulated with vehicle (CTRL) or S1P (5 mM) as indicated and incubated further for 2 h. Aldosterone secretion was determined as described in Materials and Methods. Results are expressed as described for Fig. 1 and are means 6 SEM of three independent experiments. Lower panel: Cells were treated and labeled as described for Fig. 2 and preincubated for 30 min with 5 mM EGTA (closed bars), 5 mM BAPTA-AM (gray bars), 5 mM EGTA 1 5 mM BAPTA-AM (hatched bars), or vehicle (open bars), as indicated. Ethanol (1%) was added 5 min before stimulation with vehicle or S1P (5 mM), and incubations were continued fur- ther for 30 min. PLD activity was determined by measuring the ac- cumulation of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated and expressed as described for Fig. 2 and are means 6 SEM of three independent experiments. * P , 0.05.

Journal: Journal of Lipid Research

Article Title: Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion

doi: 10.1194/jlr.m500510-jlr200

Figure Lengend Snippet: Fig. 8. Involvement of extracellular Ca21 in S1P-induced aldoste- rone secretion and PLD activation. Upper panel: Cells were treated as described for Fig. 1 and preincubated for 30 min with 5 mM EGTA (closed bars), 5 mM BAPTA-AM (gray bars), 5 mM EGTA 1 5 mM BAPTA-AM (hatched bars), or vehicle (open bars). They were then stimulated with vehicle (CTRL) or S1P (5 mM) as indicated and incubated further for 2 h. Aldosterone secretion was determined as described in Materials and Methods. Results are expressed as described for Fig. 1 and are means 6 SEM of three independent experiments. Lower panel: Cells were treated and labeled as described for Fig. 2 and preincubated for 30 min with 5 mM EGTA (closed bars), 5 mM BAPTA-AM (gray bars), 5 mM EGTA 1 5 mM BAPTA-AM (hatched bars), or vehicle (open bars), as indicated. Ethanol (1%) was added 5 min before stimulation with vehicle or S1P (5 mM), and incubations were continued fur- ther for 30 min. PLD activity was determined by measuring the ac- cumulation of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated and expressed as described for Fig. 2 and are means 6 SEM of three independent experiments. * P , 0.05.

Article Snippet: Sphingosine, S1P, N-acetylsphingosine (C2-ceramide), N-hexanoylsphingosine (C6-ceramide), and phosphatidylethanol were from Avanti Polar Lipids (Alabaster, AL).

Techniques: Activation Assay, Incubation, Labeling, Activity Assay

Fig. 9. Involvement of PKC in PLD activation by S1P in ZG cells. Upper panel: Cells were preincubated with vehicle (open bars) or 2 mM PMA for 48 h (closed bars) to downregulate PKC. Ethanol (1%) was added 5 min before stimulation with S1P (5 mM), PMA (2 mM), or vehicle, and incubations were continued further for 30 min. PLD activity was determined by measuring the accumula- tion of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated as a percentage of the radioac- tivity present in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to con- trol (CTRL) incubations. Values are means 6 SEM of three inde- pendent experiments performed in triplicate. Lower panel: Cells were preincubated for 30 min with vehicle (CTRL), 2 mM hispidine (HISP), 0.5 mM dequalinium (DEQ), 5 mM rottlerin (ROT), or 0.5 mM dequalinium 1 5 mM rottlerin (DEQ1ROT), as indicated. Ethanol (1%) was added 5 min before stimulation with 5 mM S1P or vehicle, and incubations were continued further for 30 min. Results were calculated and expressed as for the upper panel and are means 6 SEM of three independent experiments performed in triplicate. ** P , 0.01; * P , 0.05;1 P , 0.05, DEQ1ROT versus DEQ or ROT.

Journal: Journal of Lipid Research

Article Title: Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion

doi: 10.1194/jlr.m500510-jlr200

Figure Lengend Snippet: Fig. 9. Involvement of PKC in PLD activation by S1P in ZG cells. Upper panel: Cells were preincubated with vehicle (open bars) or 2 mM PMA for 48 h (closed bars) to downregulate PKC. Ethanol (1%) was added 5 min before stimulation with S1P (5 mM), PMA (2 mM), or vehicle, and incubations were continued further for 30 min. PLD activity was determined by measuring the accumula- tion of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated as a percentage of the radioac- tivity present in [3H]phosphatidylethanol compared with that in total lipids and are expressed as fold stimulation relative to con- trol (CTRL) incubations. Values are means 6 SEM of three inde- pendent experiments performed in triplicate. Lower panel: Cells were preincubated for 30 min with vehicle (CTRL), 2 mM hispidine (HISP), 0.5 mM dequalinium (DEQ), 5 mM rottlerin (ROT), or 0.5 mM dequalinium 1 5 mM rottlerin (DEQ1ROT), as indicated. Ethanol (1%) was added 5 min before stimulation with 5 mM S1P or vehicle, and incubations were continued further for 30 min. Results were calculated and expressed as for the upper panel and are means 6 SEM of three independent experiments performed in triplicate. ** P , 0.01; * P , 0.05;1 P , 0.05, DEQ1ROT versus DEQ or ROT.

Article Snippet: Sphingosine, S1P, N-acetylsphingosine (C2-ceramide), N-hexanoylsphingosine (C6-ceramide), and phosphatidylethanol were from Avanti Polar Lipids (Alabaster, AL).

Techniques: Activation Assay, Activity Assay

Fig. 11. Inhibition of S1P-stimulated PLD and aldosterone secre- tion by N-hexanoylsphingosine (C6-ceramide) in ZG cells. Upper panel: Cells were treated and labeled as described for Fig. 3. They were then preincubated in the absence (open bars) or presence (closed bars) of 10 mM C6-ceramide for 2 h in BSA-free DMEM. S1P (5 mM) was added, and incubations were continued further for 30 min in the presence of 1% ethanol. PLD activity was determined by measuring the accumulation of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated as a percentage of the radioactivity present in [3H]phosphatidylethanol compared with that in total lipids and expressed as fold stimula- tion relative to control (CTRL) incubations. Values are means 6 SEM of four independent experiments performed in triplicate. Lower panel: Cells were preincubated with vehicle (open circles) or with the indicated concentrations of C6-ceramide (closed circles) for 2 h in DMEM supplemented with 0.2% BSA. S1P (5 mM) was then added, and incubations were continued further for 2 h. Aldosterone secretion was determined as described in Materials and Methods. Results are expressed as fold stimulation relative to incubations with vehicle and are means 6 SEM of four indepen- dent experiments performed in triplicate. ** P , 0.01.

Journal: Journal of Lipid Research

Article Title: Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion

doi: 10.1194/jlr.m500510-jlr200

Figure Lengend Snippet: Fig. 11. Inhibition of S1P-stimulated PLD and aldosterone secre- tion by N-hexanoylsphingosine (C6-ceramide) in ZG cells. Upper panel: Cells were treated and labeled as described for Fig. 3. They were then preincubated in the absence (open bars) or presence (closed bars) of 10 mM C6-ceramide for 2 h in BSA-free DMEM. S1P (5 mM) was added, and incubations were continued further for 30 min in the presence of 1% ethanol. PLD activity was determined by measuring the accumulation of [3H]phosphatidylethanol as described in Materials and Methods. Results were calculated as a percentage of the radioactivity present in [3H]phosphatidylethanol compared with that in total lipids and expressed as fold stimula- tion relative to control (CTRL) incubations. Values are means 6 SEM of four independent experiments performed in triplicate. Lower panel: Cells were preincubated with vehicle (open circles) or with the indicated concentrations of C6-ceramide (closed circles) for 2 h in DMEM supplemented with 0.2% BSA. S1P (5 mM) was then added, and incubations were continued further for 2 h. Aldosterone secretion was determined as described in Materials and Methods. Results are expressed as fold stimulation relative to incubations with vehicle and are means 6 SEM of four indepen- dent experiments performed in triplicate. ** P , 0.01.

Article Snippet: Sphingosine, S1P, N-acetylsphingosine (C2-ceramide), N-hexanoylsphingosine (C6-ceramide), and phosphatidylethanol were from Avanti Polar Lipids (Alabaster, AL).

Techniques: Inhibition, Labeling, Activity Assay, Radioactivity, Control

Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; GM2, ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes

Journal: Cellular and Molecular Life Sciences: CMLS

Article Title: Cell density-dependent membrane distribution of ganglioside GM3 in melanoma cells

doi: 10.1007/s00018-023-04813-9

Figure Lengend Snippet: Binding of anti-GM3 antibody (GMR6) to GM3/partner lipid is dependent on incubation temperatures and phase transition temperatures of partner lipids. A Binding of 0.37 µg/mL of anti-GM3 antibody to indicated lipids (0.5 nmol/well) was measured by ELISA. GM1, ganglioside GM1; GM2, ganglioside GM2; GM3, ganglioside GM3; GlcCer, glucosylceramide; LacCer, lactosylceramide; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; pSM, palmitoyl sphingomyelin;Cer, ceramide; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); TOCL, 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol; CerPE, N-acyl-sphingosylphosphorylethanolamine. B Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/DOPC (1:9), GM3/POPC (1:9), GM3/DMPC (1:9) or GM3/DPPC (1:9) (0.5 nmol GM3/well) at indicated temperature measured by ELISA. (C) Binding of 0.37 µg/mL of anti-GM3 antibody to GM3/pSM (1:9), GM3/GlcCer (1:9), GM3/GM1 (1:9) or GM3 alone (0.5 nmol GM3/well) at indicated temperatures measured by ELISA. Data in A–C are means ± SD of three experiments. D Binding of anti-GM3 antibody (10 ng/mL) to GM3/DOPC (1:5) (orange) or GM3/DPPC (1:5) (green) liposomes measured by surface plasmon resonance (SPR). SPR was performed as described in Methods. E Binding of anti-GM3 antibody to DPPC/GM3 (5:2) (orange) or DPPC/GM3/Chol (5:2:5) (green) liposomes. F Binding of different concentration of anti-GM3 antibody to GM3/DPPC (1:9) liposomes

Article Snippet: GM2 (GalNAcβ1,4(Neu5Acα2,3)Galβ1,4Glcβ1,1’-ceramide) from bovine brain was from Wako Pure Chemical Industries (Osaka, Japan).

Techniques: Binding Assay, Incubation, Sublimation, Enzyme-linked Immunosorbent Assay, Liposomes, SPR Assay, Concentration Assay